{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T05:02:18Z","timestamp":1784437338389,"version":"3.55.0"},"reference-count":35,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Sciences and Technology, Taiwan","award":["MOST 108-2923-B-005-001-MY3"],"award-info":[{"award-number":["MOST 108-2923-B-005-001-MY3"]}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["19-53-52008"],"award-info":[{"award-number":["19-53-52008"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Health and Welfare","award":["109-10"],"award-info":[{"award-number":["109-10"]}]},{"name":"Feng Yuan Hospital","award":["113-06"],"award-info":[{"award-number":["113-06"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Anthraquinone-based intercalating compounds, such as doxorubicin and mitoxantrone, have long been used clinically due to their ability to induce DNA damage. More recently, heteroarene-fused anthraquinones have been developed to further enhance their anticancer activity. Among these compounds, 4,11-bis(2-(2-chloroacetamidine)ethylamino)anthra[2,3-b]thiophene-5,10-dione dihydrochloride (designated as derivative a) was identified as a potent apoptotic inducer. Based on this scaffold, two additional derivatives were synthesized by replacing the sulfur atom within the heterocyclic ring with nitrogen (derivative b) or oxygen (derivative c). Building upon our previous identification of ENOX2 as the primary target of this scaffold, the present study investigated the antiproliferative effects and underlying mechanisms of these derivatives in colon cancer cells with varying p53 statuses. Derivatives a and b effectively induced apoptosis and suppressed proliferation in p53 wild-type HCT116 cells, which was concomitantly accompanied by significant ENOX2 downregulation and the activation of intrinsic apoptotic signaling. In contrast, p53-null HCT116 cells exhibited reduced sensitivity, attenuated apoptotic responses, and minimal ENOX2 downregulation. Notably, derivative c primarily induced G2\/M arrest rather than apoptosis regardless of p53 status, indicating a predominantly cytostatic mechanism. Collectively, these findings suggest that the degree of ENOX2 modulation is linked to the distinct anti-proliferative responses induced by heteroarene-fused anthraquinones, and that p53 status serves as a critical molecular switch influencing the transition between cytostatic growth arrest and apoptotic cell death.<\/jats:p>","DOI":"10.3390\/biom16071043","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:00:52Z","timestamp":1784278852000},"page":"1043","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["p53-Dependent ENOX2 Downregulation Mediates the Apoptotic Responses to Heteroarene-Fused Anthraquinones in Colon Cancer Cells"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2445-6128","authenticated-orcid":false,"given":"Chien-Yu","family":"Chen","sequence":"first","affiliation":[{"name":"Graduate Institute of Biomedical Sciences, College of Medicine, National Chung Hsing University, Taichung 402202, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-1539","authenticated-orcid":false,"given":"Alexander S.","family":"Tikhomirov","sequence":"additional","affiliation":[{"name":"Gause Institute of New Antibiotics, 11 B. Pirogovskaya Street, Moscow 119021, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Farng","family":"Liou","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Feng-Yuan Hospital, Ministry of Health and Welfare, Taichung 42055, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Feng-Yuan Hospital, Ministry of Health and Welfare, Taichung 42055, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Han","family":"Chiu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biomedical Sciences, College of Medicine, National Chung Hsing University, Taichung 402202, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atikul","family":"Islam","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biomedical Sciences, College of Medicine, National Chung Hsing University, Taichung 402202, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6595-0811","authenticated-orcid":false,"given":"Andrey E.","family":"Shchekotikhin","sequence":"additional","affiliation":[{"name":"Gause Institute of New Antibiotics, 11 B. Pirogovskaya Street, Moscow 119021, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3200-7552","authenticated-orcid":false,"given":"Pin Ju","family":"Chueh","sequence":"additional","affiliation":[{"name":"Graduate Institute of Biomedical Sciences, College of Medicine, National Chung Hsing University, Taichung 402202, Taiwan"},{"name":"Graduate Institute of Chinese Medicine and Drug Development, College of Medicine, National Chung Hsing University, Taichung 402202, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2165\/00003495-199141030-00007","article-title":"Mitoxantrone\u2014A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in the Chemotherapy of Cancer","volume":"41","author":"Faulds","year":"1991","journal-title":"Drugs"},{"key":"ref_2","first-page":"1","article-title":"Mitoxantrone: An active new agent in the treatment of advanced breast cancer","volume":"12","author":"Bozek","year":"1984","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0014-5793(86)80703-7","article-title":"DNA sequence preferences for the anti-cancer drug mitoxanthrone and related anthraquinones revealed by DNase I footprinting","volume":"202","author":"Fox","year":"1986","journal-title":"FEBS Lett."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e202302237","DOI":"10.1002\/chem.202302237","article-title":"Exploring the Potential of Anthraquinone-Based Hybrids for Identifying a Novel Generation of Antagonists for the Smoothened Receptor in HH-Dependent Tumour","volume":"29","author":"Quaglio","year":"2023","journal-title":"Chemistry"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"118924","DOI":"10.1016\/j.ejmech.2026.118924","article-title":"Discovery of novel anthraquinone-based P2X7R antagonist that reinvigorates anti-tumor immunity and overcomes PD-1 resistance in breast cancer","volume":"315","author":"Liang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e202200436","DOI":"10.1002\/cmdc.202200436","article-title":"Deciphering the Binding Insights of Novel Disubstituted Anthraquinone Derivatives with G-Quadruplex DNA to Exhibit Selective Cancer Cell Cytotoxicity","volume":"17","author":"Roy","year":"2022","journal-title":"ChemMedChem"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"35806","DOI":"10.1039\/D1RA05686G","article-title":"Journey of anthraquinones as anticancer agents\u2014A systematic review of recent literature","volume":"11","author":"Malik","year":"2021","journal-title":"Rsc Adv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/php.13617","article-title":"Effect of Substituents on the Photodynamic Action of Anthraquinones: EPR, Computational and In Vitro Studies","volume":"98","author":"Sokkar","year":"2022","journal-title":"Photochem. Photobiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"174020","DOI":"10.1016\/j.ejphar.2021.174020","article-title":"Preparation of novel anthraquinone-based aspirin derivatives with anti-cancer activity","volume":"900","author":"Lin","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejmech.2018.12.056","article-title":"A novel class of anthraquinone-based HDAC6 inhibitors","volume":"164","author":"Song","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4155\/fmc-2019-0322","article-title":"Novel anthraquinone compounds as anticancer agents and their potential mechanism","volume":"12","author":"Tian","year":"2020","journal-title":"Future Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chang, J.S., Chen, C.Y., Tikhomirov, A.S., Islam, A., Liang, R.H., Weng, C.W., Wu, W.H., Shchekotikhin, A.E., and Chueh, P.J. (2022). Bis(chloroacetamidino)-Derived Heteroarene-Fused Anthraquinones Bind to and Cause Proteasomal Degradation of tNOX, Leading to c-Flip Downregulation and Apoptosis in Oral Cancer Cells. Cancers, 14.","DOI":"10.3390\/cancers14194719"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jare.2023.04.001","article-title":"ENOX2 inhibition enhances infiltration of effector memory T-cell and mediates response to chemotherapy in immune-quiescent nasopharyngeal carcinoma","volume":"56","author":"Kam","year":"2024","journal-title":"J. Adv. Res."},{"key":"ref_14","first-page":"649","article-title":"ENOX2 (or tNOX): A new and old molecule with cancer activity involved in tumor prevention and therapy","volume":"30","author":"Ronconi","year":"2016","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Aqel, R.S., Ismail, A.S., El-Tanani, M., and Satyam, S.M. (2026). Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A. PLoS ONE, 21.","DOI":"10.1371\/journal.pone.0345701"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2220531","DOI":"10.1080\/13510002.2023.2220531","article-title":"Tolerable treatment of glioblastoma with redox-cycling \u2018mitocans\u2019: A comparative study in vivo","volume":"28","author":"Sumiyoshi","year":"2023","journal-title":"Redox Rep."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bakalova, R., Lazarova, D., Sumiyoshi, A., Shibata, S., Zhelev, Z., Nikolova, B., Semkova, S., Vlaykova, T., Aoki, I., and Higashi, T. (2023). Redox-Cycling \u201cMitocans\u201d as Effective New Developments in Anticancer Therapy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24098435"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wang, C.W., Islam, A., Shih, Y.T., Chang, C.F., Chen, M.K., and Chueh, P.J. (2026). ENOX2 (tNOX)-Associated Stemness in Oral Cancer Cells and Its Clinical Correlation in Head and Neck Tumors. Antioxidants, 15.","DOI":"10.3390\/antiox15010098"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13039-025-00744-1","article-title":"Optical genome mapping identifies novel ENOX2::RUNX1 t(X;21)(q26.1;q22.12) rearrangement in acute myeloid leukemia-myelodysplasia related: First case report","volume":"19","author":"George","year":"2025","journal-title":"Mol. Cytogenet."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"B\u00f6cker, M., Chatziioannou, E., Niessner, H., Hirn, C., Busch, C., Ikenberg, K., Kalbacher, H., Handgretinger, R., and Sinnberg, T. (2024). Ecto-NOX Disulfide-Thiol Exchanger 2 (ENOX2\/tNOX) Is a Potential Prognostic Marker in Primary Malignant Melanoma and May Serve as a Therapeutic Target. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111853"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4274\/tjh.galenos.2023.2022-0339","article-title":"ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia","volume":"40","author":"Voldoire","year":"2023","journal-title":"Turk. J. Haematol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sumiyoshi, A., Shibata, S., Zhelev, Z., Miller, T., Lazarova, D., Aoki, I., Obata, T., Higashi, T., and Bakalova, R. (2022). Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State. Cancers, 14.","DOI":"10.3390\/cancers14030485"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Quansah, M., Fetter, L., Fineran, A., Colling, H.V., Silver, K., Rowland, T.J., and Bonham, A.J. (2023). Rapid and Quantitative Detection of Lung Cancer Biomarker ENOX2 Using a Novel Aptamer in an Electrochemical DNA-Based (E-DNA) Biosensor. Biosensensors, 13.","DOI":"10.3390\/bios13070675"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1158\/1541-7786.MCR-25-0615","article-title":"Tumor Cell-Derived Microparticles Induced by Methotrexate Reprogram Neutrophil Antitumor Response via Lysosomal ROS-Mediated Degranulation","volume":"24","author":"Zhang","year":"2026","journal-title":"Mol. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3727\/096504014X14077751730270","article-title":"ENOX2 target for the anticancer isoflavone ME-143","volume":"22","author":"Morre","year":"2014","journal-title":"Oncol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Luj\u00e1n-M\u00e9ndez, F., Rold\u00e1n-Padr\u00f3n, O., Castro-Ru\u00edz, J.E., L\u00f3pez-Mart\u00ednez, J., and Garc\u00eda-Gasca, T. (2023). Capsaicinoids and Their Effects on Cancer: The \u201cDouble-Edged Sword\u201d Postulate from the Molecular Scale. Cells, 12.","DOI":"10.3390\/cells12212573"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"87873","DOI":"10.7554\/eLife.87873.3","article-title":"Water-soluble 4-(dimethylaminomethyl)heliomycin exerts greater antitumor effects than parental heliomycin by targeting the tNOX-SIRT1 axis and apoptosis in oral cancer cells","volume":"12","author":"Islam","year":"2024","journal-title":"Elife"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"119060","DOI":"10.1016\/j.ejmech.2026.119060","article-title":"Revisiting heliomycin: Chemistry, biological activity, and perspectives for drug development","volume":"316","author":"Buravchenko","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e48602","DOI":"10.1097\/MD.0000000000048602","article-title":"ENOX2 and the related mechanisms as potential genetic targets for varicose veins of lower extremities: An integrated bioinformatics and Mendelian analysis","volume":"105","author":"He","year":"2026","journal-title":"Medicine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2249.2012.04621.x","article-title":"X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma","volume":"169","author":"Selmi","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/biof.5520280206","article-title":"Effect of polyclonal antisera to recombinant tNOX protein on the growth of transformed cells","volume":"28","author":"Chen","year":"2006","journal-title":"Biofactors"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-010715-103715","article-title":"The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies","volume":"56","author":"Nordlund","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ivashkevich, A. (2022). The role of isoflavones in augmenting the effects of radiotherapy. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.800562"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12014-016-9103-3","article-title":"ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms","volume":"13","author":"Morre","year":"2016","journal-title":"Clin. Proteom."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13046-018-0837-9","article-title":"Regulation of tNOX expression through the ROS-p53-POU3F2 axis contributes to cellular responses against oxaliplatin in human colon cancer cells","volume":"37","author":"Chen","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/7\/1043\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T04:21:32Z","timestamp":1784434892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/7\/1043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["biom16071043"],"URL":"https:\/\/doi.org\/10.3390\/biom16071043","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}